2/16/2024 0 Comments What are nod scid miceIt is the second most hematological threat with a new case rate, 7.0 per 100,000/year based on 2013–2017 cases in the United States ( National Cancer Institute: Surveillance, Epidemiology, and End Results Program, 2020). Multiple myeloma (MM) is a plasma cell (PC) malignancy that represents an accumulation of terminally differentiated monoclonal PC in the bone marrow (BM) ( Katz, 2010). As the general features of MM animal models have been reviewed elsewhere, the current review will focus on the features of MMBD animal models. In particular, MMBD has been studied in various models, and each model has unique features. MM animal models have been developed and studied in various aspects of MM tumorigenesis. Cumulative evidence shows that the interaction of MM cells and bone microenvironment plays a significant role in MM progression, suggesting that these interactions may be good targets for therapy. MMBD causes severe morbidity and increases mortality. MM bone disease (MMBD) is defined as the presence of one or more osteolytic bone lesions or diffused osteoporosis with compression fracture attributable to the underlying clonal PC disorder. It is the second most common hematological malignancy and considered an incurable disease despite significant treatment improvements. Multiple myeloma (MM) is a clonal B-cell disorder characterized by the proliferation of malignant plasma cells (PCs) in the bone marrow, the presence of monoclonal serum immunoglobulin, and osteolytic lesions. 2Department of Biosciences, Jamia Millia Islamia, New Delhi, India.1Myeloma Center, The University of Arkansas for Medical Sciences, Little Rock, AR, United States. Morris 1 Ladan Mashouri 1 Donghoon Yoon 1* It is suggested that multiple immunological dysfunctions, including cytokine production capability, in addition to functional incompetence of T, B, and NK cells, may lead to the high engraftment levels of xenograft in NOD/SCID/gamma(c)(null) mice.Syed Hassan Mehdi 1 Sana Nafees 2 Syed Jafar Mehdi 1 Carol A. The interferon-gamma production from dendritic cells from the NOD/SCID/gamma(c)(null) mouse spleen was significantly suppressed in comparison with findings in 2 other strains of mice. To elucidate the mechanisms involved in the superior engraftment rate in NOD/SCID/gamma(c)(null) mice, cytokine production of spleen cells stimulated with Listeria monocytogenes antigens was compared among these 3 strains of mice. These results suggest that NOD/SCID/gamma(c)(null) mice were superior animal recipients for xenotransplantation and were especially valuable for human stem cell assay. Further, even 1 x 10(2) CD34+ cells could grow and differentiate in this strain. In addition to the high engraftment rate, multilineage cell differentiation was also observed. The same high engraftment rate of human mature cells was observed in ascites when peripheral blood mononuclear cells were intraperitoneally transferred. When human CD34+ cells from umbilical cord blood were transplanted into this strain, the engraftment rate in the peripheral circulation, spleen, and bone marrow were significantly higher than that in NOD/Shi-scid mice treated with anti-asialo GM1 antibody or in the beta2-microglobulin-deficient NOD/LtSz-scid (NOD/SCID/beta2m(null)) mice, which were as completely defective in NK cell activity as NOD/SCID/gamma(c)(null) mice. To establish a more appropriate animal recipient for xenotransplantation, NOD/SCID/gamma(c)(null) mice double homozygous for the severe combined immunodeficiency (SCID) mutation and interleukin-2Rgamma (IL-2Rgamma) allelic mutation (gamma(c)(null)) were generated by 8 backcross matings of C57BL/6J-gamma(c)(null) mice and NOD/Shi-scid mice.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |